Board member Aaron Davis resigns from iTeos Therapeutics, effective Nov 1

iTeos Therapeutics, Inc.

Aaron Davis resigned from the Board of Directors on Oct 31, effective Nov 1, 2024.
Resignation was not due to any disagreement with the Company, management, or Board.
No replacement has been announced; Board seat is now vacant.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Aaron Davis

member of the Board of Directors

iTeos Therapeutics, Inc.

Effective: 2024-11-01
Filed: November 4, 2024, 6:59 PM ET

On October 31, 2024, Aaron Davis, a member of the Board of Directors (the “ Board ”) of iTeos Therapeutics, Inc. (the “ Company ”), resigned from the Board, effective November 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Aaron Davis resigned as member of the Board of Directors at iTeos Therapeutics, Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On October 31, 2024, Aaron Davis, a member of the Board of Directors (the “ Board ”) of iTeos Therapeutics, Inc. (the “ Company ”), resigned from the Board, effective November 1, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0000950170-24-120273

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.